Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis
Adam S. Kittai, Ying Huang, Max J. Gordon, Nathan Denlinger, Agrima Mian, Lindsey Fitzgerald, Jennifer Bishop, Sarah Nagle, Deborah M. Stephens, Samantha Jaglowski, Brian T. Hill, Alexey V. Danilov
Topics & Concepts
MedicineInternal medicineHazard ratioGastroenterologyDiffuse large B-cell lymphomaProportional hazards modelSurvival analysisLog-rank testLeukapheresisProgression-free survivalRefractory (planetary science)OncologyConfidence intervalLymphomaChemotherapyGeneticsStem cellCD34AstrobiologyPhysicsBiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentIntegrated Circuits and Semiconductor Failure Analysis